(HealthDay)—Rates of prostate-specific antigen (PSA) testing increased significantly after the 2017 U.S. Preventive Services Task Force (USPSTF) draft statement on prostate cancer screening, reversing trends that resulted ...
Dec 1, 2021
0
1
A third of insured people with cancer end up paying more out-of-pocket than they expected, despite having health coverage, researchers at the Duke Cancer Institute have found.
Aug 10, 2017
0
0
Skipping genetic counseling before or after taking a remote screening of inherited risk for ovarian or breast cancer does not increase distress, anxiety or depression, according to a study published Sept. 14 in JAMA Oncology.
Sep 19, 2023
0
6
Despite decades of clinical research establishing chemotherapy with thoracic radiation as the standard-of-care for the initial management of non-metastatic small-cell lung cancer (SCLC), a large percentage of U.S. patients ...
Jan 4, 2018
0
5
Multilevel care interventions improved clinician–documented advanced care planning (ACP) compared with a clinician-level intervention alone for patients with genitourinary cancer, according to findings published in JAMA ...
Jun 24, 2024
0
1
Results from the NRG Oncology phase I clinical trial NRG-GOG 9929 show that using the immunotherapy drug ipilimumab after chemoradiotherapy (CRT) is tolerated in the curative treatment of women with lymph node-positive cervical ...
Dec 3, 2019
0
1
The results of a national cancer survey find a significant number of childhood cancer survivors are worried about keeping their health insurance, to the point of letting it affect their career decisions. The findings were ...
Oct 19, 2017
0
31
Electronic nudges delivered to health care clinicians based on a machine learning algorithm that predicts mortality risk quadrupled rates of conversations with patients about their end-of-life care preferences, according ...
Jan 12, 2023
0
28
A new study by researchers at the Johns Hopkins Kimmel Cancer Center in collaboration with Dell Medical School, University of Minnesota, and the Vanderbilt University Medical Center, using a national data sample from the ...
Apr 20, 2023
0
3
(HealthDay)—For patients with early breast cancer, five years of zoledronate treatment after chemotherapy does not improve prognosis versus two years of treatment, according to a study published online June 24 in JAMA Oncology.
Jun 25, 2021
0
2
